Valeant Pharmaceuticals International (VRX) · page 13 of 39
The slide highlights the contradiction between Valeant's accounting consolidation of Philidor and their public claim of non-control.
Activist deck · expose_contradiction · expose_contradiction · balanced density
Slide locked Sign in to view
Slide schematic 4/4
callout 1/1 list 2/2 title 1/1
Components 4
primary bullet bullet headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 2